Who is sponsoring NCT04589481?

NCT04589481 is sponsored by University Hospital, Basel, Switzerland.

What drugs are being tested in NCT04589481?

Interventions in NCT04589481: Intake of 3 different candies against bad breath.

What condition does NCT04589481 study?

NCT04589481 studies Bad Breath.

Is NCT04589481 still recruiting?

NCT04589481 is currently completed. Last updated 2 June 2021.

Last reviewed 2021-06-02 · How we verify

NCT04589481: HALIDROP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Different Candies Against Bad Breath

Completed NA Last updated 2 June 2021

What this trial tests

NA trial testing Intake of 3 different candies against bad breath in Bad Breath in 35 participants. Completed in 1 June 2021.

Timeline

23 February 2021

Primary endpoint
1 June 2021

1 June 2021

Quick facts

Lead sponsor	University Hospital, Basel, Switzerland
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	35
Start date	23 February 2021
Primary completion	1 June 2021
Estimated completion	1 June 2021
Sites	1 location across Switzerland

Drugs / interventions tested

Intake of 3 different candies against bad breath

Conditions studied

Bad Breath — all drugs for Bad Breath →

Sponsor

University Hospital, Basel, Switzerland

Who can join

Adults 18 to 40, any sex, with Bad Breath. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to analyze whether the candies can relieve or eliminate bad breath, both subjectively and objectively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04589481 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
Last refreshed: 2 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04589481.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing